HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 83: Line 83:
|
|
|-
|-
|Juvenile myelomonocytic leukaemia||Disease|| '''Sarah Rapisardo, PhD, FACMG''' |Assistant Professor, Pathology Associate Director | Division of Molecular Pathology, Genetics and Genomics Duke University Health System Clinical Laboratories|| || || || ||FQR|| ||
|Juvenile myelomonocytic leukaemia||Disease|| '''Sarah Rapisardo, PhD, FACMG''' | || || || || ||FQR|| ||
|Juvenile Myelomonocytic Leukemia (JMML)
|<nowiki>Sarah Rapisardo, PhD, FACMG | Assistant Professor, Pathology</nowiki>
 
Associate Director | Division of Molecular Pathology, Genetics and Genomics
 
Duke University Health System Clinical Laboratories
|PENDING importing content and reference formatting
|
|
|
|FQR has emailed SR several times, last 4/20/22
|
|
|PENDING importing content and reference formatting; FQR has emailed SR several times, last 4/20/22
|-
|-
|Myeloproliferative neoplasm, NOS||Disease||Thomas Lee, MD, PhD, University of California, Los Angeles|| || || || ||FQR|| ||
|Myeloproliferative neoplasm, NOS||Disease|| || || || || ||FQR|| ||
|
|Myeloproliferative Neoplasm (MPN), Unclassifiable
|
|Thomas Lee, MD, PhD, University of California, Los Angeles
|
|Complete
|
|
|
|